glycerol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karaosmanoglu Yoneten, K | 1 |
| Kasap, M | 1 |
| Arga, KY | 1 |
| Akpinar, G | 1 |
| Utkan, NZ | 1 |
| Yuan, SJ | 1 |
| Xu, YH | 1 |
| Wang, C | 1 |
| An, HC | 1 |
| Xu, HZ | 1 |
| Li, K | 1 |
| Komatsu, N | 1 |
| Zhao, L | 1 |
| Chen, X | 1 |
2 other studies available for glycerol and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Decreased serum levels of glycerol-3- phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Glycerol; Humans; Male; Monoacylglycerol Lipases; Oxido | 2022 |
Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytostatic Agents; Doxorubicin; Drug Resistance, N | 2019 |